Mesima, Sanghwang · 2010 · Patent
Medium relevanceCOMPOSITION FOR INHIBITION OF TRANSPLANT REJECTION CONTAINING THE PHELLINUS LINTEUS MYCELLIA EXTRACT AS AN ACTIVE INGREDIENT
Phellinus linteus
Key points
- Disclosed is a composition for the inhibition of transplant rejection and the prevention and treatment of skin diseases, comprising a Phellinus sp. mycelial extract as an active ingredient
- The Phellinus sp. mycelial extract significantly suppresses the production of antibodies to transplants without side effects, such as weight change
- Based on natural material, the composition is non-toxic and harmless to the human body and thus can be used as an immunosuppressant for organ transplantation
- Also, it stops oozing from sores and is applicable to the prevention and treatment of skin diseases, including atopy, allergic reactions, decubitus ulcers, and smallpox
From the paper
Abstract
Disclosed is a composition for the inhibition of transplant rejection and the prevention and treatment of skin diseases, comprising a Phellinus sp. mycelial extract as an active ingredient. The Phellinus sp. mycelial extract significantly suppresses the production of antibodies to transplants without side effects, such as weight change. Based on natural material, the composition is non-toxic and harmless to the human body and thus can be used as an immunosuppressant for organ transplantation. Also, it stops oozing from sores and is applicable to the prevention and treatment of skin diseases, including atopy, allergic reactions, decubitus ulcers, and smallpox.
Citation
HAN MAN WOO, YOO JAE KUK, HUR CHANG-UK, KIM HWAN-CHUL, KIM JIN PYO (2010). COMPOSITION FOR INHIBITION OF TRANSPLANT REJECTION CONTAINING THE PHELLINUS LINTEUS MYCELLIA EXTRACT AS AN ACTIVE INGREDIENT.
Open citation